Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: Patriot Scientific Reports Favorable Fiscal Q3 Net Income of $9.6M, or $0.02 Dil

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

Patriot Scientific Reports Favorable Fiscal Q3 Net Income of $9.6M, or $0.02 Dil

Sedley

Apr 24, 2007 05:03AM

s402005

Rank: Treasurer [?]

Points: 5795 [?]

Votes: 78 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Patriot Scientific Reports Favorable Fiscal Q3 Net Income of $9.6M, or $0.02 Dil

in response to

Patriot Scientific Reports Favorable Fiscal Q3 Net Income of $9.6M, or $0.02 Dil

Sedley

posted on Apr 24, 2007 05:33AM

I am really surprised to read an Pr concnerning our Q3. That's ok and the first step to be more agrassvie on the market to atract more investors.